Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies
David V. Herin, Craig R. Rush, John Grabowski
Annals of the New York Academy of Sciences (2010) Vol. 1187, Iss. 1, pp. 76-100
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Neuroscience of Behavioral and Pharmacological Treatments for Addictions
Marc N. Potenza, Mehmet Sofuoglu, Kathleen M. Carroll, et al.
Neuron (2011) Vol. 69, Iss. 4, pp. 695-712
Open Access | Times Cited: 209
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder
Frances R. Levin, John J. Mariani, Sheila Specker, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 6, pp. 593-593
Open Access | Times Cited: 153
Dopamine and addiction: what have we learned from 40 years of research
Marcello Solinas, Pauline Belujon, Pierre‐Olivier Fernagut, et al.
Journal of Neural Transmission (2018) Vol. 126, Iss. 4, pp. 481-516
Open Access | Times Cited: 125
Pharmacotherapy of amphetamine‐type stimulant dependence: An update
Matthew Brensilver, Keith G. Heinzerling, Steven Shoptaw
Drug and Alcohol Review (2013) Vol. 32, Iss. 5, pp. 449-460
Open Access | Times Cited: 121
The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors
Kyle C. Schmitt, Maarten E. A. Reith
PLoS ONE (2011) Vol. 6, Iss. 10, pp. e25790-e25790
Open Access | Times Cited: 118
Evidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
Wimk van den Brink
Current Drug Abuse Reviews (2012) Vol. 5, Iss. 1, pp. 3-31
Closed Access | Times Cited: 112
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat
Michael H. Baumann, Robert D. Clark, William L. Woolverton, et al.
Journal of Pharmacology and Experimental Therapeutics (2011) Vol. 337, Iss. 1, pp. 218-225
Open Access | Times Cited: 107
A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction
G Galloway, Raymond Buscemi, Jeremy Coyle, et al.
Clinical Pharmacology & Therapeutics (2010) Vol. 89, Iss. 2, pp. 276-282
Open Access | Times Cited: 99
Maternal separation altered behavior and neuronal spine density without influencing amphetamine sensitization
Arif Muhammad, Bryan Kolb
Behavioural Brain Research (2011) Vol. 223, Iss. 1, pp. 7-16
Closed Access | Times Cited: 96
Efficacy of psychostimulant drugs for amphetamine abuse or dependence
Clara Pérez‐Mañá, Xavier Castells, Marta Torrens, et al.
Cochrane library (2013) Vol. 2013, Iss. 9
Closed Access | Times Cited: 87
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence
Kathleen T. Brady, Kevin M. Gray, Bryan K. Tolliver
Pharmacology Biochemistry and Behavior (2011) Vol. 99, Iss. 2, pp. 285-294
Open Access | Times Cited: 84
Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial
Mascha Nuijten, Peter Blanken, Ben van de Wetering, et al.
The Lancet (2016) Vol. 387, Iss. 10034, pp. 2226-2234
Closed Access | Times Cited: 79
Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies
Benedikt Fischer, Peter Blanken, Dartiu Xavier da Silveira, et al.
International Journal of Drug Policy (2015) Vol. 26, Iss. 4, pp. 352-363
Closed Access | Times Cited: 75
Psychostimulant addiction treatment
Karran A. Phillips, David H. Epstein, Kenzie L. Preston
Neuropharmacology (2014) Vol. 87, pp. 150-160
Open Access | Times Cited: 73
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
Margaret C. Wardle, Jessica Vincent, Robert Suchting, et al.
Journal of Substance Abuse Treatment (2016) Vol. 72, pp. 32-39
Open Access | Times Cited: 72
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder
Walter Ling, Linda Chang, Maureen Hillhouse, et al.
Addiction (2014) Vol. 109, Iss. 9, pp. 1489-1500
Open Access | Times Cited: 71
Agonist Medications for the Treatment of Cocaine Use Disorder
S. Stevens Negus, Jack E. Henningfield
Neuropsychopharmacology (2014) Vol. 40, Iss. 8, pp. 1815-1825
Open Access | Times Cited: 70
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64
Sustained Release d-Amphetamine Reduces Cocaine but not ‘Speedball’-Seeking in Buprenorphine-Maintained Volunteers: A Test of Dual-Agonist Pharmacotherapy for Cocaine/Heroin Polydrug Abusers
Mark K. Greenwald, Leslie H. Lundahl, Caren L. Steinmiller
Neuropsychopharmacology (2010) Vol. 35, Iss. 13, pp. 2624-2637
Open Access | Times Cited: 68
Extended‐release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
S. Wayne Miles, Janie Sheridan, Bruce Russell, et al.
Addiction (2013) Vol. 108, Iss. 7, pp. 1279-1286
Closed Access | Times Cited: 60
Future pharmacological treatments for substance use disorders
Ariadna Forray, Mehmet Sofuoglu
British Journal of Clinical Pharmacology (2012) Vol. 77, Iss. 2, pp. 382-400
Open Access | Times Cited: 59
Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
William W. Stoops, Craig R. Rush
Current Pharmaceutical Design (2013) Vol. 19, Iss. 40, pp. 7026-7035
Open Access | Times Cited: 59
Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice
Betina González, Mariana Raineri, Jean Lud Cadet, et al.
Neuropharmacology (2014) Vol. 87, pp. 188-197
Open Access | Times Cited: 58
Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation
Joy M. Schmitz, Nuvan Rathnayaka, Charles E. Green, et al.
Frontiers in Psychiatry (2012) Vol. 3
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top